PointState Capital LP Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$7.0B
Holdings
116
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (116 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | RVNCEURRevance Therapeutics Inc | 175,000 | $3.6B | 52.13% | |
| 102 | —La Jolla Pharmaceutical Co | 184,360 | $3.2B | 46.50% | |
| 103 | —Alibaba Group Hldg Ltd | 36,300 | $3.2B | 45.85% | Call |
| 104 | XOPUSDSpdr Series Trust | 69,100 | $2.9B | 41.18% | |
| 105 | —Colucid Pharmaceuticals Inc | 76,968 | $2.8B | 40.32% | |
| 106 | SNYSanofi | 7,305,164 | $2.8B | 39.94% | |
| 107 | SGENEURSeattle Genetics Inc | 50,000 | $2.6B | 37.97% | |
| 108 | CSXCsx Corp | 65,200 | $2.3B | 33.71% | |
| 109 | MPCMarathon Pete Corp | 44,600 | $2.2B | 32.32% | |
| 110 | —Centennial Resource Dev Inc | 139,732 | $1.2B | 16.98% | |
| 111 | LVLNSpdr Series Trust | 18,100 | $1.0B | 14.47% | |
| 112 | TEXTerex Corp New | 31,800 | $1.0B | 14.43% | |
| 113 | BERYEURBerry Plastics Group Inc | 19,719 | $961.0M | 13.83% | |
| 114 | WMBWilliams Cos Inc Del | 9,700 | $302.0M | 4.35% | |
| 115 | —Oncobiologics Inc | 100,000 | $79.0M | 1.14% | |
| 116 | —Oncobiologics Inc | 100,000 | $19.0M | 0.27% |
PreviousPage 2 of 2